Citalopram hydrobromide
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292019This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C20H21FN2O.BrH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I1E9D14F36, chemically known as 1,3-dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile but more generally known as citalopram hydrobromide, which bears US NIH Compound Identifier 2771. European Medicines Agency schedules Citalopram hydrobromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01320MIG. Most nations, for tariff and trade purposes, schedule citalopram hydrobromide under HS 29329985 and SITC 51569. As of Q4 2014, CITALOPRAM HYDROBROMIDE remains US FDA's Preferred Term for this commodity. Citalopram hydrobromide bears US NLM identifiers UMLS ID C0724555 and NCI Concept Code C28932. SMILES: CN(C)CCCC1(C2CCC(CC2CO1)C#N)C3CCC(CC3)F.BR.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.